374 related articles for article (PubMed ID: 16902180)
21. Molecular signaling mediated by angiotensin II type 1A receptor blockade leading to attenuation of renal dysfunction-associated heart failure.
Li Y; Takemura G; Okada H; Miyata S; Maruyama R; Esaki M; Kanamori H; Li L; Ogino A; Ohno T; Kondo T; Nakagawa M; Minatoguchi S; Fujiwara T; Fujiwara H
J Card Fail; 2007 Mar; 13(2):155-62. PubMed ID: 17395057
[TBL] [Abstract][Full Text] [Related]
22. Blockage of angiotensin II type 2 receptor prevents thyroxine-mediated cardiac hypertrophy by blocking Akt activation.
Carneiro-Ramos MS; Diniz GP; Nadu AP; Almeida J; Vieira RL; Santos RA; Barreto-Chaves ML
Basic Res Cardiol; 2010 May; 105(3):325-35. PubMed ID: 20155476
[TBL] [Abstract][Full Text] [Related]
23. Urotensin II induces rat cardiomyocyte hypertrophy via the transient oxidization of Src homology 2-containing tyrosine phosphatase and transactivation of epidermal growth factor receptor.
Liu JC; Chen CH; Chen JJ; Cheng TH
Mol Pharmacol; 2009 Dec; 76(6):1186-95. PubMed ID: 19755521
[TBL] [Abstract][Full Text] [Related]
24. Chronic angiotensin II stimulation in the heart produces an acquired long QT syndrome associated with IK1 potassium current downregulation.
Domenighetti AA; Boixel C; Cefai D; Abriel H; Pedrazzini T
J Mol Cell Cardiol; 2007 Jan; 42(1):63-70. PubMed ID: 17070838
[TBL] [Abstract][Full Text] [Related]
25. Regulator of G-protein signaling subtype 4 mediates antihypertrophic effect of locally secreted natriuretic peptides in the heart.
Tokudome T; Kishimoto I; Horio T; Arai Y; Schwenke DO; Hino J; Okano I; Kawano Y; Kohno M; Miyazato M; Nakao K; Kangawa K
Circulation; 2008 May; 117(18):2329-39. PubMed ID: 18443239
[TBL] [Abstract][Full Text] [Related]
26. Regulated overexpression of the A1-adenosine receptor in mice results in adverse but reversible changes in cardiac morphology and function.
Funakoshi H; Chan TO; Good JC; Libonati JR; Piuhola J; Chen X; MacDonnell SM; Lee LL; Herrmann DE; Zhang J; Martini J; Palmer TM; Sanbe A; Robbins J; Houser SR; Koch WJ; Feldman AM
Circulation; 2006 Nov; 114(21):2240-50. PubMed ID: 17088462
[TBL] [Abstract][Full Text] [Related]
27. Integrin-linked kinase expression is elevated in human cardiac hypertrophy and induces hypertrophy in transgenic mice.
Lu H; Fedak PW; Dai X; Du C; Zhou YQ; Henkelman M; Mongroo PS; Lau A; Yamabi H; Hinek A; Husain M; Hannigan G; Coles JG
Circulation; 2006 Nov; 114(21):2271-9. PubMed ID: 17088456
[TBL] [Abstract][Full Text] [Related]
28. IRF3 regulates cardiac fibrosis but not hypertrophy in mice during angiotensin II-induced hypertension.
Tsushima K; Osawa T; Yanai H; Nakajima A; Takaoka A; Manabe I; Ohba Y; Imai Y; Taniguchi T; Nagai R
FASEB J; 2011 May; 25(5):1531-43. PubMed ID: 21266535
[TBL] [Abstract][Full Text] [Related]
29. Overexpression of prostaglandin EP3 receptors activates calcineurin and promotes hypertrophy in the murine heart.
Meyer-Kirchrath J; Martin M; Schooss C; Jacoby C; Flögel U; Marzoll A; Fischer JW; Schrader J; Schrör K; Hohlfeld T
Cardiovasc Res; 2009 Feb; 81(2):310-8. PubMed ID: 19019835
[TBL] [Abstract][Full Text] [Related]
30. The antifibrotic agent pirfenidone inhibits angiotensin II-induced cardiac hypertrophy in mice.
Yamazaki T; Yamashita N; Izumi Y; Nakamura Y; Shiota M; Hanatani A; Shimada K; Muro T; Iwao H; Yoshiyama M
Hypertens Res; 2012 Jan; 35(1):34-40. PubMed ID: 21866107
[TBL] [Abstract][Full Text] [Related]
31. Senescence marker protein 30 inhibits angiotensin II-induced cardiac hypertrophy and diastolic dysfunction.
Misaka T; Suzuki S; Miyata M; Kobayashi A; Ishigami A; Shishido T; Saitoh S; Kubota I; Takeishi Y
Biochem Biophys Res Commun; 2013 Sep; 439(1):142-7. PubMed ID: 23933320
[TBL] [Abstract][Full Text] [Related]
32. Cardioprotective effects of granulocyte colony-stimulating factor in angiotensin II-induced cardiac remodelling.
Jia N; Dong P; Huang Q; Jin W; Zhang J; Dai Q; Liu S
Clin Exp Pharmacol Physiol; 2009 Mar; 36(3):262-6. PubMed ID: 18785976
[TBL] [Abstract][Full Text] [Related]
33. Apoptosis signal-regulating kinase 1 plays a pivotal role in angiotensin II-induced cardiac hypertrophy and remodeling.
Izumiya Y; Kim S; Izumi Y; Yoshida K; Yoshiyama M; Matsuzawa A; Ichijo H; Iwao H
Circ Res; 2003 Oct; 93(9):874-83. PubMed ID: 14551246
[TBL] [Abstract][Full Text] [Related]
34. Activation of Na+/H+ exchanger 1 is sufficient to generate Ca2+ signals that induce cardiac hypertrophy and heart failure.
Nakamura TY; Iwata Y; Arai Y; Komamura K; Wakabayashi S
Circ Res; 2008 Oct; 103(8):891-9. PubMed ID: 18776042
[TBL] [Abstract][Full Text] [Related]
35. Transgenic overexpression of the secreted, extracellular EGF-CUB domain-containing protein SCUBE3 induces cardiac hypertrophy in mice.
Yang HY; Cheng CF; Djoko B; Lian WS; Tu CF; Tsai MT; Chen YH; Chen CC; Cheng CJ; Yang RB
Cardiovasc Res; 2007 Jul; 75(1):139-47. PubMed ID: 17442284
[TBL] [Abstract][Full Text] [Related]
36. Inhibition of histone deacetylation blocks cardiac hypertrophy induced by angiotensin II infusion and aortic banding.
Kee HJ; Sohn IS; Nam KI; Park JE; Qian YR; Yin Z; Ahn Y; Jeong MH; Bang YJ; Kim N; Kim JK; Kim KK; Epstein JA; Kook H
Circulation; 2006 Jan; 113(1):51-9. PubMed ID: 16380549
[TBL] [Abstract][Full Text] [Related]
37. Mechanical stress-evoked but angiotensin II-independent activation of angiotensin II type 1 receptor induces cardiac hypertrophy through calcineurin pathway.
Zhou N; Li L; Wu J; Gong H; Niu Y; Sun A; Ge J; Zou Y
Biochem Biophys Res Commun; 2010 Jun; 397(2):263-9. PubMed ID: 20580688
[TBL] [Abstract][Full Text] [Related]
38. Cardiac BNP gene activation by angiotensin II in vivo.
Majalahti T; Suo-Palosaari M; Sármán B; Hautala N; Pikkarainen S; Tokola H; Vuolteenaho O; Wang J; Paradis P; Nemer M; Ruskoaho H
Mol Cell Endocrinol; 2007 Jul; 273(1-2):59-67. PubMed ID: 17587490
[TBL] [Abstract][Full Text] [Related]
39. Pressure overload induces greater hypertrophy and mortality in female mice with p38alpha MAPK inhibition.
Liu J; Sadoshima J; Zhai P; Hong C; Yang G; Chen W; Yan L; Wang Y; Vatner SF; Vatner DE
J Mol Cell Cardiol; 2006 Oct; 41(4):680-8. PubMed ID: 16928383
[TBL] [Abstract][Full Text] [Related]
40. Erythropoietin attenuates hypertrophy of neonatal rat cardiac myocytes induced by angiotensin-II in vitro.
Wen Y; Zhang XJ; Ma YX; Xu XJ; Hong LF; Lu ZH
Scand J Clin Lab Invest; 2009; 69(4):518-25. PubMed ID: 19347742
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
